An Expanded Access Study of Bemarituzumab (FPA144) for a Single Patient With Recurrent Bladder Cancer
Clinical trial NCT03801278 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT03801278
- Sponsor
- Five Prime Therapeutics, Inc.
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.